How RTU Solutions Can Meet GMP Annex 1 Requirements

Abstract

The updated EU GMP Annex 1 guidelines have introduced heightened expectations around contamination control, quality risk management, and the implementation of comprehensive Contamination Control Strategies (CCS) for sterile manufacturing operations. These requirements are driving pharmaceutical companies to reassess their fill & finish processes, seeking solutions that can help reduce operational complexity while maintaining the highest quality standards.

In this webinar, experts from Stevanato Group explore how Ready-to-Use (RTU) vial and cartridge platforms can support Annex 1 compliance by eliminating critical preparation steps such as washing, depyrogenation, and sterilization. It will be illustrated how sterilized containment solutions can help reduce contamination risks, simplify manufacturing operations, improve process efficiency, and accelerate time-to-market while supporting robust contamination control strategies.

Key Learning Objectives:

• Understand the key GMP Annex 1 updates and their impact on sterile manufacturing operations, contamination control strategies (CCS), and quality risk management approaches.
• Learn how Ready-to-Use vial and cartridge platforms can help reduce operational complexity by eliminating washing, depyrogenation, and sterilization activities while minimizing contamination risks.
• Discover the operational, quality, and time-to-market advantages that RTU solutions can provide compared with conventional container preparation processes.